Henry Schein Market Cap 2006-2018 | HSIC
Henry Schein market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Henry Schein market cap as of November 16, 2018 is $13.12B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.120B | $12.462B |
| Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics and other alternate care sites. The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of branded products and Henry Schein private-brand products in stock. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Becton Dickinson (BDX) | United States | $65.839B | 22.43 |
| McKesson (MCK) | United States | $24.205B | 9.25 |
| AmerisourceBergen (ABC) | United States | $19.202B | 13.70 |
| Align Technology (ALGN) | United States | $18.029B | 46.00 |
| Laboratory Of America Holdings (LH) | United States | $16.578B | 15.00 |
| Cardinal Health (CAH) | United States | $16.524B | 11.09 |
| Cooper (COO) | United States | $13.024B | 23.45 |
| DENTSPLY SIRONA (XRAY) | United States | $8.279B | 16.53 |
| West Pharmaceutical Services (WST) | United States | $8.159B | 40.49 |
| Merit Medical Systems (MMSI) | United States | $3.360B | 39.79 |
| Patterson (PDCO) | United States | $2.427B | 17.06 |
| CONMED (CNMD) | United States | $1.929B | 32.05 |
| STAAR Surgical (STAA) | United States | $1.784B | 183.77 |
| Atrion (ATRI) | United States | $1.343B | 38.40 |
| Antares Pharma (ATRS) | United States | $0.532B | 0.00 |
| Invacare (IVC) | United States | $0.189B | 0.00 |
| Lifevantage (LFVN) | United States | $0.161B | 22.84 |
| Endologix (ELGX) | United States | $0.106B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.061B | 27.17 |
| Aceto (ACET) | United States | $0.055B | 0.00 |
| Biolase (BIOL) | United States | $0.027B | 0.00 |
| Retractable Technologies (RVP) | United States | $0.022B | 0.00 |
| Milestone Scientific (MLSS) | United States | $0.019B | 0.00 |
